Sort
21,453 grants matching “tuberculosis”
Evolutionary and Functional Significance of Novel Mutations in MDR-XDR TB
$704,061Faramarz Valafar · San Diego State University · R01 · FY2014 · AI
B cells and humoral immunity in tuberculosis
$703,554John R. Chan · Albert Einstein College Of Medicine · R01 · FY2014 · AI
New drugs for non-tuberculous mycobacterial (NTM) lung disease in patients with cystic fibrosis
$703,425Thomas Dick · Hackensack University Medical Center · U19 · FY2023 · AI
Admixture Mapping of Sarcoidosis Genes in African American
$703,335Benjamin A. Rybicki · Henry Ford Health System · R01 · FY2009 · HL
A novel cartridge-based sequencing solution for decentralized M. tuberculosis resistance detection
$703,128John Zapata Metcalfe · University Of California, San Francisco · R01 · FY2024 · AI
Translational approaches to improve understanding and outcome in Tuberculous meningitis
$703,053Martin Alfons Gengenbacher · Hackensack University Medical Center · R01 · FY2023 · AI
Simulating Protein Structures, Complexes, And Dynamics
$703,010Peter J Steinbach · Center For Information Technology · ZIA · FY2014 · CT
A Community Mycobacterial Systems Resource
$702,919Keith M Derbyshire · Wadsworth Center · R01 · FY2014 · AI
Technology Core - The Center for Innovation in Point-of-Care Technologies for HIV/AIDS and Emerging Infectious Diseases at Northwestern University (C-THAN)
$702,878Sally M McFall · Northwestern University · U54 · FY2024 · EB
Development of a highly-multiplexed CRISPR-based TB drug susceptibility test
$702,499Yingda Linda Xie · Rutgers Biomedical And Health Sciences · R01 · FY2025 · AI
TUBERCULOSIS ELIMINATION AND LABORATORY
$702,310Weston R Ruhrig · Pennsylvania State Dept Of Health · U52 · FY2006 · PS
Strengthening evidence on optimal multidrug-resistant tuberculosis treatment regimens through improved epidemiologic methods
$702,282Molly Forrest Franke · Harvard Medical School · R01 · FY2021 · AI
Genetic and metabolic determinants of multiple drug resistance in tuberculosis
$702,104Megan B Murray · Brigham And Women'S Hospital · U19 · FY2010 · AI
TUBERCULOSIS ELIMINATION AND LABORATORY COOPERATIVE AGREEMENTS
$702,061Robert Lee Brawley · Ky St Cabinet/Health/Family Services · U52 · FY2011 · PS
CELL WALL OF M TUBERCULOSIS: FOCUS FOR DRUG DISCOVERY
$701,902Colorado State University-Fort Collins · P01 · FY2000 · AI
Non-canonical epitope presentation and antigen processing by MHC-E
$701,712Klaus J Frueh · Oregon Health & Science University · R01 · FY2024 · AI
INDIANA STATE DEPT OF HEALTH TUBERCULOSIS ELIMINATION AND LABORATORY COOPERATIVE
$701,470Sarah Burkholder · Indiana State Department Of Health · U52 · FY2014 · PS
International Research in Korea: Clinical Studies of Drug-Resistant Tuberculosis
$701,341Clifton Barry · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Nanoreactor beads for POC TB resistance testing
$701,248David Alland · Rutgers Biomedical And Health Sciences · R01 · FY2024 · AI
Regulation Of Immunopathology In Bacterial And Parasitic Disease
$701,240Alan Sher · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Defining adaptive immune responses to Mtb-infection and TB disease among young children with and without HIV-exposure
$701,086Christina Louise Lancioni · Oregon Health & Science University · R01 · FY2023 · AI
Personalized Antimicrobial Combinations to Combat Resistance
$700,989Vincent H Tam · University Of Houston · R01 · FY2022 · AI
Personalized Antimicrobial Combinations to Combat Resistance
$700,989Vincent H Tam · University Of Houston · R01 · FY2021 · AI
Finding and Treating Unsuspected and Resistant TB to Reduce Hospital Transmission
$700,912Edward A. Nardell · Brigham And Women'S Hospital · R01 · FY2016 · AI
Epidemiology of Helicobacter Pylori Transmission
$700,789Julie Parsonnet · Stanford University · R01 · FY2010 · AI